S. Skolnik

发表

Optimization of the in vitro cardiac safety of hydroxamate-based histone deacetylase inhibitors.

F. Lombardo, P. Atadja, S. Whitebread, 2011, Journal of medicinal chemistry.

Recent Advances in Physicochemical and ADMET Profiling in Drug Discovery

Suzanne Skolnik, Jianling Wang, S. Skolnik, 2009, Chemistry & biodiversity.

Mitigating permeability-mediated risks in drug discovery

Suzanne Skolnik, Jianling Wang, S. Skolnik, 2010, Expert opinion on drug metabolism & toxicology.

Path (Probe ADME and Test Hypotheses): A Useful Approach Enabling Hypothesis‐Driven ADME Optimization

D. Bednarczyk, S. Skolnik, Leslie Bell, 2014 .

Paradoxical Increase of Permeability and Lipophilicity with the Increasing Topological Polar Surface Area within a Series of PRMT5 Inhibitors.

D. Bednarczyk, Y. Cho, S. Skolnik, 2022, Journal of medicinal chemistry.

Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents

K. Kuhen, E. Winzeler, Chun Xing Li, 2012, Journal of medicinal chemistry.

Attenuation of Intestinal Absorption by Major Efflux Transporters: Quantitative Tools and Strategies Using a Caco-2 Model

Suzanne Skolnik, Jianling Wang, Xuena Lin, 2011, Drug Metabolism and Disposition.

Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents

K. Kuhen, E. Winzeler, Chun Xing Li, 2011, Journal of medicinal chemistry.

Prediction of pKa Using Machine Learning Methods with Rooted Topological Torsion Fingerprints: Application to Aliphatic Amines

Peter Gedeck, Brian Kelley, Weiping Jia, 2019, J. Chem. Inf. Model..

Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay.

Xuena Lin, S. Skolnik, Bailin Zhang, 2010, Journal of pharmaceutical sciences.

Automated Supersaturation Stability Assay to Differentiate Poorly Soluble Compounds in Drug Discovery.

S. Skolnik, S. Dodd, G. Geraci, 2018, Journal of pharmaceutical sciences.

Discovery solubility measurement and assessment of small molecules with drug development in mind.

S. Skolnik, Wenzhan Yang, K. Patros, 2022, Drug discovery today.

Developing Collaborative QSAR Models Without Sharing Structures

Peter Gedeck, Stephane Rodde, Suzanne Skolnik, 2017, J. Chem. Inf. Model..

ADMET Diagnosis Models

B. Faller, S. Skolnik, Jianling Wang, 2014 .

Permeability diagnosis model in drug discovery: a diagnostic tool to identify the most influencing properties for gastrointestinal permeability.

Suzanne Skolnik, Jianling Wang, S. Skolnik, 2013, Current topics in medicinal chemistry.

Recent Advances in Physicochemical and ADMET Profiling in Drug Discovery

S. Skolnik, Jianling Wang, 2009, Chemistry and Biodiversity.

Benefit of Retraining pKa Models Studied Using Internally Measured Data

Peter Gedeck, Franco Lombardo, Weiping Jia, 2015, J. Chem. Inf. Model..

Avoid missing pKas: High-throughput workflow using solution pH-metric in tandem with UV-metric measurements.

S. Skolnik, Linhong Yang, 2023, Journal of pharmaceutical and biomedical analysis.